This study looked at the effect of vitamin D levels in reducing the risk of full-blown diabetes in people with prediabetes. They found that having high levels of vitamin D reduced the risk of developing diabetes. 

This study looked at the treatment of type 2 diabetes with either daily or weekly insulin injections. They found that weekly insulin was as safe and effective as daily injections.

This study looked at the risk of dementia in patients with type 2 diabetes (T2D) taking metformin (Glucophage) and those not taking this drug. They found that patients taking metformin were at a lower risk to develop dementia.

This study looked at the risk of heart disease, stroke, and other complications in diabetic patients with low thyroid function (hypothyroidism; HT). They found that diabetic patients with HT were not at increased risk of major heart disease or stroke. However, these patients were more likely to develop diabetic eye disease and kidney disease.

This study looked at the effect of vitamin D supplements on diabetic neuropathy (DN; nerve damage). They found that taking high-dose vitamin D for 6 months reduced the pain and disability associated with DN.

This study investigated the risk of foot amputation (removal of the foot or part of it) in patients with diabetic foot ulcers to see what factors increase this risk. They found that being male, smoking, and having a history of previous foot ulcers all increased the risk of amputation.  

This study compared real-time continuous glucose monitoring (CGM) to flash CGM for patients with type 1 diabetes (T1D). It found that real-time CGM led to better glucose control and less hypoglycemia, both during daily activity and exercise.

This study examined the role of statin (cholesterol-lowering) therapy in lowering the risk of diabetic eye disease and sight-threatening complications of diabetes. They found that patients taking a statins were less likely to suffer from advanced diabetic eye disease than those not taking a statin.  

This review looked at the effect of chromium supplements for patients with type 2 diabetes (T2D). It found that chromium supplements improved blood glucose and insulin levels for these patients.

This analysis compared diabetes treatments for how much of the time blood sugar is in the target range. It found that closed-loop systems, which combine a continuous glucose monitor (CGM) and insulin pump, led to better outcomes for people with type 1 diabetes (T1D).